» Articles » PMID: 26349975

MiRNA-144 Suppresses Proliferation and Migration of Colorectal Cancer Cells Through GSPT1

Overview
Date 2015 Sep 10
PMID 26349975
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs play a key role in carcinogenesis or tumor progression, which negatively and posttranscriptionally regulate gene expression and function as oncogenes or tumor suppressors, as well as regulators of cell cycle, proliferation, apoptosis, migration and other processes. A number of miRNAs are reported be related to the occurrence and development of colorectal cancer (CRC). However, these studies were not involved in the effect of miRNA 144 of CRC, whose function remains unclear. In this study, we demonstrated that the expression level of miRNA 144 was markedly down-regulated in colorectal cancer HCT116 cells compared with normal control FHC cells. Meanwhile, we found that GSPT1 was over-expressed in human colorectal cancer HCT116 cells. Subsequently, GSPT1 was identified as a target of miRNA 144 through bioinformatics and luciferase reporter assays. Besides, we also confirmed that miRNA 144 can inhibit the proliferation and migration of colorectal cancer HCT116 cells . Next, we observed RNA-mediated knockdown of GSPT1 can also inhibit the proliferation and migration of colorectal cancer cells. Thus, we concluded that miRNA 144 inhibits cell proliferation and migration through GSPT1 in CRC. In addition, further mechanic investigations revealed that miRNA-144 suppressed the expression of GSPT1 to regulate the expression of c-myc, survivin and Bcl2L15 which are involved in cell proliferation, and that metastasis related factor MMP28 was also down-regulated by miRNA144. Our findings suggested that microRNA 144 might be an important element to control the status of colorectal cancer, which has provided a new insight into the mechanism of proliferation and migration and a new target in therapy against colorectal cancer.

Citing Articles

Identification of prognostic biomarkers of sepsis and construction of ceRNA regulatory networks.

Chen G, Zhang W, Wang C, Chen M, Hu Y, Wang Z Sci Rep. 2025; 15(1):2850.

PMID: 39843498 PMC: 11754875. DOI: 10.1038/s41598-024-78502-3.


Prognostic biomarkers based on , and targets affecting migration of gastric cancer cells.

Ma H, Suo L, Zhao J, Ma R, Wang Q, Liu J Transl Cancer Res. 2024; 13(9):4827-4845.

PMID: 39430826 PMC: 11483415. DOI: 10.21037/tcr-24-125.


Non-coding RNA-related antitumor mechanisms of marine-derived agents.

Zhou Z, Cao Q, Diao Y, Wang Y, Long L, Wang S Front Pharmacol. 2022; 13:1053556.

PMID: 36532760 PMC: 9752855. DOI: 10.3389/fphar.2022.1053556.


GSPT1 Functions as a Tumor Promoter in Human Liver Cancer.

Xi Y, Gao J, Li X, Xu L, Li Z, Yang L Curr Med Sci. 2022; 43(1):104-114.

PMID: 36459303 DOI: 10.1007/s11596-022-2665-6.


Therapeutic Potential of miRNAs for Type 2 Diabetes Mellitus: An Overview.

Palihaderu P, Mendis B, Premarathne J, Dias W, Yeap S, Ho W Epigenet Insights. 2022; 15:25168657221130041.

PMID: 36262691 PMC: 9575458. DOI: 10.1177/25168657221130041.